The current pregnant women living with hiv antiretroviral therapy coverage for pmtct of El Salvador is 78%, an increase of 2% (2.6%) compared to 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in El Salvador
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,975
Measure:
%
Similar regions to El Salvador
More indicators for El Salvador
Male unintentional poisoning
1.2
0.0
(2021)
Female wasting in children
2.7%
+1%
(2021)
Female prevalence of HIV
0.1%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar343
+intl dollar31
(2022)
Birth registration
91.2%
-7.3%
(2018)
Contraceptive modern method prevalence
52.1%
-15.6%
(2021)
El Salvador PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | Value | Change |
|---|---|---|
| 2022 | 78% | +2% |
| 2021 | 76% | +17% |
| 2020 | 59% | -8% |
| 2019 | 67% | +9% |
| 2018 | 58% | -10% |
| 2017 | 68% | +3% |
| 2016 | 65% | -4% |
| 2015 | 69% | -1% |
| 2014 | 70% | -4% |
| 2013 | 74% | +9% |
| 2012 | 65% | +20% |
| 2011 | 45% | +6% |
| 2010 | 39% | -7% |
| 2009 | 46% | -8% |
| 2008 | 54% | +1% |
| 2007 | 53% | -13% |
| 2006 | 66% | -23% |
| 2005 | 89% | -7% |
| 2004 | 96% | +25% |
| 2003 | 71% | +23% |
| 2002 | 48% | +48% |
| 2001 | 0% | 0% |
| 2000 | 0% |